Correlation Between Kancera AB and Corline Biomedical

Can any of the company-specific risk be diversified away by investing in both Kancera AB and Corline Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kancera AB and Corline Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kancera AB and Corline Biomedical AB, you can compare the effects of market volatilities on Kancera AB and Corline Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kancera AB with a short position of Corline Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kancera AB and Corline Biomedical.

Diversification Opportunities for Kancera AB and Corline Biomedical

0.41

Correlation Coefficient

Kancera AB  Corline Biomedical

Very weak diversification

The 3 months correlation between Kancera and Corline is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Kancera AB and Corline Biomedical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corline Biomedical and Kancera AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kancera AB are associated (or correlated) with Corline Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corline Biomedical has no effect on the direction of Kancera AB i.e., Kancera AB and Corline Biomedical go up and down completely randomly.

Pair Corralation between Kancera AB and Corline Biomedical

Assuming the 90 days trading horizon Kancera AB is expected to generate 2.19 times less return on investment than Corline Biomedical. In addition to that, Kancera AB is 1.9 times more volatile than Corline Biomedical AB. It trades about 0.15 of its total potential returns per unit of risk. Corline Biomedical AB is currently generating about 0.62 per unit of volatility. If you would invest  746.00  in Corline Biomedical AB on October 8, 2024 and sell it today you would earn a total of  238.00  from holding Corline Biomedical AB or generate 31.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kancera AB  vs.  Corline Biomedical AB

Kancera AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Corline Biomedical

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Corline Biomedical AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Corline Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Kancera AB and Corline Biomedical

The main advantage of trading using opposite Kancera AB and Corline Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kancera AB position performs unexpectedly, Corline Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corline Biomedical will offset losses from the drop in Corline Biomedical's long position.

The idea behind Kancera AB and Corline Biomedical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.